Free Trial
→ Claim Your Share of $5.39 BILLION in AI Equity Checks (From Angel Publishing) (Ad)tc pixel

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover
10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.251 of 5 stars		$13.324.5%N/A-4.76Buy$33.50
Ultragenyx Pharmaceutical (RARE)
4.3838 of 5 stars		$29.474.8%N/A-5.33Moderate Buy$81.50
Sarepta Therapeutics (SRPT)
4.4159 of 5 stars		$18.657.0%N/A-21.44Hold$39.32
Pfizer (PFE)
4.9867 of 5 stars		$24.050.1%7.15%12.79Hold$28.12
Exelixis (EXEL)
4.6779 of 5 stars		$39.58-1.3%N/A19.03Moderate Buy$44.42
Moderna (MRNA)
4.4576 of 5 stars		$26.565.2%N/A-3.53Hold$41.81
United Therapeutics (UTHR)
4.6475 of 5 stars		$414.73-0.7%N/A16.19Moderate Buy$438.85
Biogen (BIIB)
4.6763 of 5 stars		$140.66-1.3%N/A13.45Hold$181.65
Sanofi (SNY)
4.0187 of 5 stars		$47.01-1.3%3.40%11.30Buy$62.67
Eli Lilly and Company (LLY)
4.997 of 5 stars		$755.320.4%0.79%49.37Moderate Buy$939.61
Compare These Stocks  Add These Stocks to My Watchlist